STE

Steris Plc

252.30

Nov 06 • 3:59 PM ET -1.82 (-0.72%)

252.10

Aftermarket • 7:31 PM ET -0.20 (-0.08%)

Healthcare Medical Devices Ireland Large NYSE

Peers: SHC SOLV MDLN SYK BAX BDX FTV TFX ECL MLAB

| Held by: VTI VOO VO IVV SPY RSP VTV XLV SDY IHI

Scroll to Statements

Index	S&P 500
Market Cap	24.60B
Enterprise Value	26.13B
Income	827.00M
Sales	6.17B
Book/sh	74.74
Cash/sh	5.45
Dividend Est.	2.69 (1.07%)
Dividend TTM	2.58 (1.02%)
Dividend Ex-Date	Nov 17, 2026
Dividend Gr. 3/5Y	10.16% 9.40%
Payout	31.04%
Employees	17937
IPO	Jun 01, 1992

P/E	29.93
Forward P/E	20.42
PEG	2.05
P/S	3.99
P/B	3.38
P/C	46.32
P/FCF	26.25
EV/EBITDA	15.11
EV/Sales	4.24
Quick Ratio	1.44
Current Ratio	2.05
Debt/Eq	0.28
LT Debt/Eq	0.24
Option/Short	Yes / Yes

EPS (ttm)	8.43
EPS next Y	12.35
EPS next Q	2.80
EPS this Y	12.25%
EPS next Y	8.22%
EPS next 5Y	9.94%
EPS past 3/5Y	95.07% 11.37%
Sales past 3/5Y	9.38% 13.82%
EPS Y/Y TTM	19.88%
Sales Y/Y TTM	8.13%
EPS Q/Q	12.73%
Sales Q/Q	8.79%
Earnings	Nov 04 AMC
EPS/Sales Surpr.	9.68% 2.43%

Insider Own	0.34%
Insider Trans	-3.32%
Inst Own	100.25%
Inst Trans	-0.26%
ROA	7.83%
ROE	11.59%
ROIC	9.16%
Gross Margin	45.23%
Oper. Margin	20.02%
Profit Margin	13.41%
SMA20	9.70%
SMA50	14.38%
SMA200	12.52%
Trades

Shs Outstand	97.50M
Shs Float	97.17M
Short Float	2.47%
Short Ratio	3.42
Short Interest	2.40M
52W High	269.44 -6.36%
52W Low	195.14 29.29%
Volatility	3.45% 2.67%
ATR (14)	6.58
RSI (14)	73.06
Beta	0.81
Rel Volume	1.98
Avg Volume	701.27K
Volume	1,389,598

Perf Week	11.09%
Perf Month	19.71%
Perf Quarter	5.60%
Perf Half Y	21.62%
Perf YTD	-0.48%
Perf Year	-2.98%
Perf 3Y	16.00%
Perf 5Y	12.34%
Perf 10Y	286.13%
Recom	2.00
Target Price	275.17
Prev Close	254.12
Price	252.30
Change %	-0.72%

Consensus

Buy

Avg. Price Target

$275.17

Implied Upside

+9.1%

Analysts13incl. previous ratings

Rating Distribution8 Buy · 5 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jul 28, 2026	Initiated	UUBS	Buy	$275	+9.0%
Jul 15, 2025	Upgrade	MMorgan Stanley	Equal-Weight → Overweight	$276	+9.4%
May 29, 2025	Initiated	JJefferies	Hold	$263	+4.2%
Oct 24, 2024	Upgrade	PPiper Sandler	Neutral → Overweight	$230 → $260	+3.1%
Feb 06, 2024	Resumed	KKeyBanc Capital Markets	Overweight	$253	+0.3%
May 30, 2023	Initiated	MMorgan Stanley	Equal-Weight	$206	-18.4%
Apr 14, 2023	Downgrade	PPiper Sandler	Overweight → Neutral	$215 → $197	-21.9%
Sep 23, 2022	Downgrade	NNeedham	Buy → Hold
Jul 14, 2022	Initiated	PPiper Sandler	Overweight	$240	-4.9%
Apr 07, 2022	Initiated	WWolfe Research	Outperform	$275	+9.0%
May 26, 2021	Upgrade	NNeedham	Hold → Buy	$233	-7.6%
Feb 04, 2021	Upgrade	KKeyBanc Capital Markets	Sector Weight → Overweight
Sep 02, 2020	Initiated	RRobert W. Baird	Outperform	$175	-30.6%
Jun 09, 2020	Initiated	NNeedham	Hold
Jul 10, 2019	Downgrade	KKeyBanc Capital Markets	Overweight → Sector Weight
Jan 03, 2018	Downgrade	RRaymond James	Outperform → Mkt Perform
Jun 05, 2017	Downgrade	WWellington Shields	Gradually Accumulate → Hold
May 03, 2017	Upgrade	KKeyBanc Capital Mkts	Sector Weight → Overweight
Nov 30, 2016	Initiated	GGoldman	Neutral	$71	-71.9%
Jun 03, 2016	Upgrade	NNorthcoast	Neutral → Buy

Nov-05-26 12:14PM	STERIS Beats And Raises, But Tariff Refunds And One Big Life Sciences Order Flatter A Quarter With Softer Margins Underneath (Earnings Whispers)
Nov-04-26 04:42PM	Steris: Fiscal Q2 Earnings Snapshot (Associated Press) +7.16%
04:30PM	STERIS Announces Financial Results for Fiscal 2027 Second Quarter (GlobeNewswire)
Oct-29-26 07:03AM	Bracco announces $230 million Sanford investment, 200 jobs (The Sanford Herald, N.C.)
Oct-28-26 04:30PM	STERIS Announces Dividend of $0.69 per share (GlobeNewswire)
08:14PM	Loading…
Oct-27-26 08:14PM	STERIS Needs Its Fiscal Second Quarter To Set Up A Back-Loaded Year (Earnings Whispers)
Oct-20-26 04:30PM	STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026 (GlobeNewswire)
Oct-13-26 10:00AM	Steris inks $2.1B Xodus buyout to expand consumables portfolio (MedTech Dive)
08:41AM	Steris outlays $2.1bn to acquire Xodus Medical (Medical Device Network)
Oct-12-26 02:43PM	Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE) (PR Newswire)
09:11AM	Steris to Acquire Xodus Medical for $2.1 Billion (The Wall Street Journal)
08:00AM	STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety (GlobeNewswire)
Sep-01-26 04:30PM	STERIS to Present at the Morgan Stanley Healthcare Conference (GlobeNewswire)
Aug-06-26 07:57AM	Steris to invest $600M in North Carolina manufacturing hub (Manufacturing Dive)
07:00AM	STERIS chooses Sanford for $600 million manufacturing campus (The Sanford Herald, N.C.)
04:44PM	Loading…
Aug-05-26 04:44PM	Steris: Fiscal Q1 Earnings Snapshot (Associated Press)
04:30PM	STERIS Announces Financial Results for Fiscal 2027 First Quarter (GlobeNewswire)
08:45AM	STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina (GlobeNewswire)
Jul-30-26 04:30PM	STERIS Raises Dividend to $0.69 per share (GlobeNewswire)
Jul-27-26 04:30PM	STERIS to Host a Conference Call for Fiscal 2027 First Quarter on August 6, 2026 (GlobeNewswire) +5.47%
May-12-26 07:01PM	Steris PLC (STE) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook (GuruFocus.com)
04:30PM	Steris PLC stock outperforms competitors on strong trading day (MarketWatch)
May-11-26 04:52PM	Steris: Fiscal Q4 Earnings Snapshot (Associated Press)
04:30PM	STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year (GlobeNewswire)
May-07-26 04:30PM	STERIS Appoints Pierre Boulud to Board of Directors (GlobeNewswire)
May-05-26 04:30PM	STERIS Announces Dividend of $0.63 per share (GlobeNewswire)
Apr-21-26 04:30PM	STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026 (GlobeNewswire)
Apr-09-26 06:30AM	Teleflex Announces Governance Updates (Business Wire)
Mar-16-26 03:40AM	Is STERIS Stock Underperforming the Nasdaq? (Barchart)
Mar-06-26 11:30AM	Steris (STE) Down 2.2% Since Last Earnings Report: Can It Rebound? (Zacks)
08:41AM	Loading…
Mar-05-26 08:41AM	Is DexCom Stock Underperforming the Nasdaq? (Barchart)
Feb-20-26 07:27AM	Is Wall Street Bullish or Bearish on STERIS Stock? (Barchart)
Feb-15-26 06:53AM	STERIS plc (STE) Remains in Focus as Analysts Reaffirm Confidence (Insider Monkey)
Feb-11-26 12:35AM	The 5 Most Interesting Analyst Questions From STERIS's Q4 Earnings Call (StockStory)
Feb-09-26 09:15AM	Steris (STE) International Revenue Performance Explored (Zacks)
Feb-07-26 01:13AM	STERIS Q3 Earnings Call Highlights (MarketBeat)
Feb-05-26 07:46PM	Analyst Report: STERIS plc (Morningstar Research) -7.74%
04:00PM	Steris PLC (STE) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges (GuruFocus.com)
09:25AM	STE Q3 Earnings Meet, Revenues Beat, Stock Dips in Aftermarket Trading (Zacks)
Feb-04-26 06:00PM	Compared to Estimates, Steris (STE) Q3 Earnings: A Look at Key Metrics (Zacks)
05:40PM	Steris (STE) Meets Q3 Earnings Estimates (Zacks)
04:54PM	STERIS (NYSE:STE) Beats Q4 CY2025 Sales Expectations (StockStory)
04:39PM	Steris: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:30PM	STERIS Announces Financial Results for Fiscal 2026 Third Quarter (GlobeNewswire)
11:55AM	Reasons to Hold Veeva Systems Stock in Your Portfolio for Now (Zacks)
Feb-03-26 10:29AM	Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test (Zacks)
08:29AM	MedTech Stocks to Watch for Earnings on Feb. 4: BSX, ALGN & More (Zacks)
Feb-02-26 10:17PM	What To Expect From STERIS's (STE) Q4 Earnings (StockStory)
09:51AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
Jan-30-26 12:07PM	SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval (Zacks)
Jan-29-26 12:47PM	Reasons to Add AngioDynamics Stock to Your Portfolio for Now (Zacks)
Jan-28-26 04:30PM	STERIS Announces Dividend of $0.63 per share (GlobeNewswire)
12:35PM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
12:31PM	OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System (Zacks)
07:26AM	STERIS' Q3 Earnings on Deck: What's in Store for the Stock? (Zacks)
Jan-27-26 11:47AM	BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry (Zacks)
Jan-23-26 11:43AM	ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
Jan-22-26 12:32PM	Here's Why You Should Retain INSP Stock in Your Portfolio for Now (Zacks)
Jan-21-26 04:30PM	STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026 (GlobeNewswire)
10:49AM	CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February (Zacks)
07:58AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
Jan-20-26 04:30PM	METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors (Business Wire)
Jan-19-26 12:34PM	SNN Boosts Shoulder Repair Portfolio With Integrity Orthopaedics Deal (Zacks)
12:31PM	Here's Why You Should Hold DaVita Stock in Your Portfolio for Now (Zacks)
Jan-16-26 09:27AM	3 Undervalued Medical Instrument Stocks Poised to Grow in 2026 (Zacks)
Jan-15-26 10:37AM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
08:24AM	BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies (Zacks)
Jan-14-26 10:31PM	Surgical Equipment & Consumables - Diversified Stocks Q3 Earnings: STERIS (NYSE:STE) Best of the Bunch (StockStory)
10:48AM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
10:44AM	Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety (Zacks)
Jan-12-26 08:09AM	Illumina's New Connected Multiomics Platform Set to Boost Its Stock (Zacks)
Jan-09-26 09:08AM	Is it the Right Time to Add STERIS Stock to Your Portfolio? (Zacks)
Jan-08-26 06:02AM	STERIS Earnings Preview: What to Expect (Barchart)
Dec-26-25 12:00PM	What Makes Steris (STE) a New Buy Stock (Zacks)
Dec-16-25 09:45AM	Why Steris (STE) is a Top Growth Stock for the Long-Term (Zacks)
Dec-10-25 07:57AM	Is STERIS Stock Outperforming the S&P 500? (Barchart)
Dec-09-25 11:47AM	These 3 Stocks Are Healthcare Leaders. Bullish Charts Show It. (Barrons.com)
11:32AM	New Healthcare Leaders Emerge. 3 Stocks With Bullish Charts. (Barrons.com)
Dec-05-25 11:30AM	Why Is Steris (STE) Up 0.4% Since Last Earnings Report? (Zacks)
Dec-04-25 08:27AM	Should You Hold STERIS Stock in Your Portfolio for Now? (Zacks)
Dec-03-25 11:03PM	1 Reason to Avoid STE and 1 Stock to Buy Instead (StockStory)
Nov-20-25 12:00PM	Steris (STE) Upgraded to Buy: Here's Why (Zacks)
09:11AM	Are Wall Street Analysts Bullish on STERIS Stock? (Barchart)
Nov-10-25 09:15AM	Interpreting Steris (STE) International Revenue Trends (Zacks)
Nov-07-25 09:37PM	Analyst Report: STERIS plc (Morningstar Research)
Nov-06-25 04:15PM	Steris PLC (STE) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Improved Margins ... (GuruFocus.com) +6.94%
11:37AM	Why Is STERIS (STE) Stock Rocketing Higher Today (StockStory)
08:29AM	STE Stock Gains on Q2 Earnings and Revenue Beat, '26 EPS View Up (Zacks)
Nov-05-25 07:00PM	Here's What Key Metrics Tell Us About Steris (STE) Q2 Earnings (Zacks)
05:50PM	Steris (STE) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
05:04PM	STERIS (NYSE:STE) Posts Better-Than-Expected Sales In Q3 (StockStory)
04:51PM	Steris: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:30PM	STERIS Announces Financial Results for Fiscal 2026 Second Quarter (GlobeNewswire)
Nov-04-25 06:05PM	Masimo (MASI) Q3 Earnings and Revenues Top Estimates (Zacks)
09:15AM	Seeking Clues to Steris (STE) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Nov-03-25 10:04PM	STERIS (STE) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-30-25 05:10PM	DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Oct-29-25 04:30PM	STERIS Announces Dividend of $0.63 per share (GlobeNewswire)
Oct-23-25 11:56AM	Do You Believe in the Growth Potential of STERIS (STE)? (Insider Monkey)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Breeden Richard C	Director	Aug 18 '26	Proposed Sale	231.90	4,110	953,114		Aug 18 05:25 PM
Sohi Mohsen	Director	Aug 12 '26	Option Exercise	86.23	4,058	349,921	28,363	Aug 12 04:33 PM
Sohi Mohsen	Director	Aug 12 '26	Sale	235.78	4,058	956,795	24,305	Aug 12 04:33 PM
Sohi Mohsen	Director	Aug 12 '26	Proposed Sale	235.78	4,058	956,779		Aug 12 04:06 PM
Zangerle John Adam	Sr. VP, Gen Counsel, and Sec.	Jun 15 '26	Sale	209.28	1,419	296,968	35,259	Jun 16 04:31 PM
Zangerle John Adam	Officer	Jun 15 '26	Proposed Sale	209.28	1,419	296,968		Jun 15 04:06 PM
Carestio Daniel A	President and CEO	Jun 04 '26	Sale	214.64	3,054	655,511	65,021	Jun 08 04:31 PM
Carestio Daniel A	President and CEO	Jun 05 '26	Sale	212.00	1,374	291,288	63,647	Jun 08 04:31 PM
Carestio Daniel A	Officer	Jun 05 '26	Proposed Sale	212.00	1,374	291,288		Jun 05 04:06 PM
Breeden Richard C	Director	Jun 02 '26	Option Exercise	71.40	3,781	269,963	40,445	Jun 04 04:31 PM
Breeden Richard C	Director	Jun 02 '26	Sale	209.51	1,481	310,284	38,964	Jun 04 04:31 PM
Carestio Daniel A	Officer	Jun 04 '26	Proposed Sale	214.64	3,054	655,511		Jun 04 04:13 PM
Breeden Richard C	Director	Jun 02 '26	Proposed Sale	209.51	1,481	310,285		Jun 02 04:18 PM
FELDMANN CYNTHIA L	Director	Mar 05 '26	Option Exercise	152.32	3,098	471,887	3,803	Mar 06 04:32 PM
FELDMANN CYNTHIA L	Director	Mar 05 '26	Sale	237.21	3,098	734,877	705	Mar 06 04:32 PM
FELDMANN CYNTHIA L	Director	Mar 05 '26	Proposed Sale	237.21	3,098	734,867		Mar 05 04:04 PM
Madsen Julia	Sr. VP and GM, Life Sciences	Nov 21 '25	Option Exercise	128.22	5,008	642,139	13,582	Nov 25 04:39 PM
Madsen Julia	Sr. VP and GM, Life Sciences	Nov 21 '25	Sale	262.00	5,008	1,312,096	10,710	Nov 25 04:39 PM
Madsen Julia	Officer	Nov 21 '25	Proposed Sale	262.00	5,008	1,312,096		Nov 21 04:51 PM
Tamaro Renato	V.P. & Corporate Treasurer	Nov 18 '25	Option Exercise	182.22	3,536	644,330	10,731	Nov 20 04:31 PM
Tamaro Renato	V.P. & Corporate Treasurer	Nov 18 '25	Sale	257.55	5,036	1,297,040	5,695	Nov 20 04:31 PM
Tamaro Renato	Officer	Nov 18 '25	Proposed Sale	257.55	5,036	1,297,033		Nov 18 04:46 PM
Zangerle John Adam	Sr. VP, Gen Counsel, and Sec.	Nov 11 '25	Option Exercise	69.72	15,000	1,045,800	48,669	Nov 13 04:34 PM
Zangerle John Adam	Sr. VP, Gen Counsel, and Sec.	Nov 11 '25	Sale	265.14	15,000	3,977,100	33,669	Nov 13 04:34 PM
Zangerle John Adam	Officer	Nov 11 '25	Proposed Sale	265.14	15,000	3,977,050		Nov 12 01:26 PM

STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.

PresidentMr. Daniel A. Carestio

Senior VPMs. Karen L. Burton

Senior VPMr. John Adam Zangerle

SVP & Chief Human Resources OfficerMs. Mary Clare Fraser

Senior VP & President of HealthcareMr. Cary L. Majors

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STE

Steris Plc

Upgrade your Finviz experience